In particular, in Kelch-like ECH-associated protein 1 (KEAP1) mutant non-small cell lung cancer (NSCLC), the overexpression of FSP1 induced cross-resistance to GPX4 inhibitors [131]. The gene discussed is KEAP1; the disease is non-small cell lung carcinoma.